EV Biologics, Inc. (YECO)
OTCMKTS · Delayed Price · Currency is USD
0.0810
0.00 (0.00%)
At close: Aug 7, 2025
EV Biologics Market Cap
EV Biologics has a market cap or net worth of $828.26 thousand as of August 15, 2025. Its market cap has decreased by -92.47% in one year.
Market Cap
828.26K
Enterprise Value
n/a
Revenue
9.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.08
Market Cap Chart
Since June 29, 2015, EV Biologics's market cap has decreased from 70.39M to 828.26K, a decrease of -98.82%. That is a compound annual growth rate of -35.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 828.26K | -15.18% |
| Dec 31, 2024 | 976.52K | -90.45% |
| Dec 20, 2023 | 10.23M | -56.18% |
| Dec 28, 2022 | 23.33M | 109.88% |
| Dec 31, 2021 | 11.12M | -83.80% |
| Dec 31, 2020 | 68.63M | 4,887.29% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 781.22M |
| Tian'an Technology Group | 628.15M |
| Glass House Brands | 567.91M |
| Elite Pharmaceuticals | 567.29M |
| American Oncology Network | 379.23M |
| Northwest Biotherapeutics | 362.70M |
| CytoDyn | 344.75M |